David Matthew Stark - 28 Jul 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Exec. VP Chief Legal Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for David M. Stark
Issuer symbol
TEVA
Transactions as of
28 Jul 2022
Net transactions value
-$525,590
Form type
4
Filing time
29 Jul 2022, 07:02:19 UTC
Previous filing
08 Mar 2022
Next filing
09 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Sale $525,590 -58,163 -95% $9.04 2,974 28 Jul 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.035 to $9.04, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.